Cargando…

Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma

A substantial proportion of prostatic adenocarcinoma (PRAD) patients experience biochemical failure (BCF) after radical prostatectomy (RP). The immune microenvironment plays a vital role in carcinogenesis and the development of PRAD. This study aimed to identify a novel immune‐related gene (IRG)‐bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hai‐Bo, Zeng, Yan‐Ru, Han, Zhao‐Dong, Zhuo, Yang‐Jia, Liang, Ying‐Ke, Hon, Chi Tin, Wan, Song, Wu, Shulin, Dahl, Douglas, Zhong, Wei‐De, Wu, Chin‐Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486177/ https://www.ncbi.nlm.nih.gov/pubmed/34252262 http://dx.doi.org/10.1111/cas.15062

Ejemplares similares

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
por: Menor, Mark, et al.
Publicado: (2019)

Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
por: Zeng, Ruijie, et al.
Publicado: (2021)

A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Zhai, Wen-Yu, et al.
Publicado: (2022)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Xu, Qian, et al.
Publicado: (2021)

The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification
por: Yang, Yefan, et al.
Publicado: (2022)

The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma
por: Zhuo, Xingxing, et al.
Publicado: (2022)

Identification of endoplasmic reticulum stress-related signature characterizes the tumor microenvironment and predicts prognosis in lung adenocarcinoma
por: Wan, Li, et al.
Publicado: (2023)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
por: Yi, Ming, et al.
Publicado: (2021)

Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer
por: Wang, Hao, et al.
Publicado: (2019)

An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma
por: Zhao, Xiaowen, et al.
Publicado: (2022)

A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma
por: Zhou, Emily, et al.
Publicado: (2020)

The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
por: Yao, Kai, et al.
Publicado: (2023)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021)

Risk stratification and prognosis prediction based on inflammation‐related gene signature in lung squamous carcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Integrative learning in developing an immunologic lncRNA signature as a consensus risk-stratification tool for lung adenocarcinoma
por: Chen, Zijian, et al.
Publicado: (2023)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Detection of extraprostatic extension by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted combined with systemic template prostate biopsy
por: Chuang, Hao-Wen, et al.
Publicado: (2023)

Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
por: Lin, Dagui, et al.
Publicado: (2021)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review
por: Bu, Fan, et al.
Publicado: (2022)

Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma
por: Han, Chen, et al.
Publicado: (2021)

Lipid metabolism-related gene signatures for predicting the prognosis of lung adenocarcinoma
por: Cao, Xueting, et al.
Publicado: (2023)

Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Development of novel gene signatures for the risk stratification of prognosis and diagnostic prediction of osteosarcoma patients using bioinformatics analysis
por: Li, Guoquan, et al.
Publicado: (2022)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma
por: Zhai, Wen-Yu, et al.
Publicado: (2022)

HOXB13 and TFF3 can contribute to the prognostic stratification of prostate adenocarcinoma
por: Timofte, Andrei Daniel, et al.
Publicado: (2021)

Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma
por: Wu, Zixuan, et al.
Publicado: (2022)

Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma
por: Long, Shengrong, et al.
Publicado: (2023)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
por: Song, Qian, et al.
Publicado: (2019)

Clinicopathological and oncological significance of persistent prostate-specific antigen after radical prostatectomy: A systematic review and meta-analysis
por: Wu, Shulin, et al.
Publicado: (2023)

An anoikis-related gene signature for prediction of the prognosis in prostate cancer
por: Zhao, Xiaodong, et al.
Publicado: (2023)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer
por: Du, Feng, et al.
Publicado: (2022)

Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer
por: Fei, Hongjun, et al.
Publicado: (2023)

A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer
por: Zeng, Yan-Ru, et al.
Publicado: (2015)

A novel pyroptosis related genes signature for predicting prognosis and estimating tumor immune microenvironment in lung adenocarcinoma
por: Wu, Chunting, et al.
Publicado: (2022)

Individualized prognosis stratification in muscle invasive bladder cancer: A pairwise TP53-derived transcriptome signature
por: Liu, Hua-Ping, et al.
Publicado: (2023)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sfegtqiovvg8fkusroeimr4jac